Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-19
    E.g., 2018-10-19

Articles

51890 items
12:00 AM, Oct 12, 2000  |  BC Extra | Company News

Schwarz and Alviva in CNS development

Schwarz (Monheim, Germany) obtained access to a group of compounds from Alviva (Saskatoon, Saskatchewan) to address neurodegenerative diseases such as Parkinson's, Alzheimer's, Huntingdon's and Amyotrophic Lateral Sclerosis (ALS). Schwarz will pay Alviva milestones and license...
12:00 AM, Oct 12, 2000  |  BC Extra | Company News

Celera completes sequencing of mouse genome

A week following the announcement of the Mouse Sequencing Consortium, CRA announced it has completed sequencing of 9.3 billion base pairs of mouse genome. The company, which began sequencing the mouse in April, said it...
12:00 AM, Oct 12, 2000  |  BC Extra | Company News

Trega licensing deal with Johnson & Johnson

JNJ companies the R.W. Johnson Pharmaceutical Research Institute (Raritan, N.J.) and Janssen Research Foundation (Beerse, Belgium) licensed the absorption and metabolism modules of TRGA's iDEA predictive models that simulate how drugs are processed in the...
12:00 AM, Oct 12, 2000  |  BC Extra | Financial News

Onyx raises $45 million

ONXX closed a follow-on offering of 3 million shares at $15 a share to raise $45 million. U.S. Bancorp Piper Jaffray was the lead manager, with CIBC World Markets acting as co-manager. The overallotment is...
12:00 AM, Oct 12, 2000  |  BC Extra | Financial News

Introgen sells IPO

Introgen (INGN) raised $32 million through the sale of 4 million shares at $8. The deal was underwritten by SG Cowen; PaineWebber; and Prudential Vector and has a 600,000-share overallotment. INGN is a gene therapy...
12:00 AM, Oct 12, 2000  |  BC Extra | Financial News

Genomics Collaborative raises $36.2 million

Genomics Collaborative ( Cambridge, Mass.), a genomics company based on large-scale association studies, raised $36.2 million in a private round. Lead investors included Invesco Private Capital; Whitney & Co; AGTC Funds; Oracle Partners; the Economic...
12:00 AM, Oct 12, 2000  |  BC Extra | Top Story

Thursday market watch

The BioCentury 100 fell 3 percent on Thursday, and has posted a loss on eight out of the last nine trading days. Thursday's drop was in line with the falls on the NASDAQ and DJIA,...
12:00 AM, Oct 12, 2000  |  BC Extra | Company News

Senetek receives U.K. approval for Invicorp

The U.K. granted marketing approval for SNTKY's Invicorp self-injected combination of vasoactive intestinal polypeptide and phentolamine to treat erectile dysfunction....
12:00 AM, Oct 12, 2000  |  BC Extra | Financial News

Inhale sells bumped up note deal

INHL raised $200 million through the sale of convertible subordinated notes. The notes bear a 3.5 percent coupon, mature in 2007 and convert into INHL common stock at $50.46 per share. On Monday, INHL filed...
12:00 AM, Oct 12, 2000  |  BC Extra | Company News

Martek European patent revoked

The European Patent Office revoked MATK's European patent covering docosahexaenoic acid (DHA), an oil used in infant formula and nutritional supplements. The decision was a result of challenges made by competitors of the company. The...

Pages